NAFDAC approves AstraZeneca COVID-19 vaccine

209

The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the use of AstraZeneca Vaccine for use in Nigeria.

The Director-General of the agency, Mojisola Adeyeye, made the announcement at a press briefing in Abuja on Thursday.

The NAFDAC boss said the vaccine can be stored at two to eight degree centigrade.

According to the Adeyeye, NAFDAC got the dossier of the vaccine a week ago, and its safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.

She added that there are three additional vaccines undergoing evaluation.

Adeyeye disclosed that the South African variant has not been reported in Nigeria, adding that the agency has over 30 herbal medicine undergoing review for listing.

 




Leave a Reply

Your email address will not be published. Required fields are marked *